Genetic Engineering News & Biotechnology News (GEN), the only high-frequency publication dedicated to biotechnology news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide. Our readership penetration covers the global bioscience industry.
Our unique editorial mandate spans the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. The only publication with this news mandate, we are uniquely positioned in the industry to have the broadest, most effective reach for your commercial message.
Contact our advertising department to learn about opportunities that profit from GEN's extensive reach and internationally respected brand name. GEN is the publication of record for bioindustry news and the most effective vehicle for disseminating your marketing message to your target bioscience audience.
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Listen
Save
Comment
View All